Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ANAB
INBX
Add up to 3 more stocks
ANAB
AnaptysBio, Inc.
-2.66%
$47.89-1.31Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.42B
52W Range
$19.65 - $72.36
INBX
Inhibrx Biosciences Inc.
-1.22%
$93.41-1.15Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.37B
52W Range
$28.16 - $155.29
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 8.92 | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 133.96 | N/A |
| P/S Ratio | 5.97 | N/A |
| P/FCF Ratio | 78.62 | N/A |
| EV/EBITDA | 11.44 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 99.0% | -91.0% |
| Operating Margin | 20.4% | -10386.5% |
| Net Margin | 82.4% | -10773.5% |
| ROE | 1849.1% | N/A |
| ROA | 61.8% | -89.6% |
| ROIC | 47.5% | -99.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.61 | 5.07 |
| Quick Ratio | 5.61 | 5.07 |
| Debt/Equity | 25.47 | N/A |
| Interest Coverage | 0.60 | -11.07 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.